APA (7th ed.) Citation

Alping, P. (2023). Disease‐modifying therapies in multiple sclerosis: A focused review of rituximab. Basic & Clinical Pharmacology & Toxicology, 133(5), 550. https://doi.org/10.1111/bcpt.13932

Chicago Style (17th ed.) Citation

Alping, Peter. "Disease‐modifying Therapies in Multiple Sclerosis: A Focused Review of Rituximab." Basic & Clinical Pharmacology & Toxicology 133, no. 5 (2023): 550. https://doi.org/10.1111/bcpt.13932.

MLA (9th ed.) Citation

Alping, Peter. "Disease‐modifying Therapies in Multiple Sclerosis: A Focused Review of Rituximab." Basic & Clinical Pharmacology & Toxicology, vol. 133, no. 5, 2023, p. 550, https://doi.org/10.1111/bcpt.13932.